Prostate Cancer - Results from #760

Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis. June 5, 2024

Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation. June 5, 2024

Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review. June 4, 2024

Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis. June 4, 2024

Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer. June 4, 2024

Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states. June 4, 2024

Automated prostate gland segmentation in challenging clinical cases: comparison of three artificial intelligence methods. June 4, 2024

An artificial intelligence model for detecting pathological lymph node metastasis in prostate cancer using whole slide images: a retrospective, multicentre, diagnostic study. June 4, 2024

An integrated radiology-pathology machine learning classifier for outcome prediction following radical prostatectomy: Preliminary findings. June 4, 2024

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. June 4, 2024

Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). June 3, 2024

Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies. June 3, 2024

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. June 3, 2024

International Variations in Surgical Quality of Care in Men With Prostate Cancer: Results From the TrueNTH Global Registry. June 3, 2024

Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. June 3, 2024

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. May 31, 2024

Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing Analysis. May 31, 2024

Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis. May 31, 2024

Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer. May 31, 2024

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. May 31, 2024

Page 39 of 1434